Clinical trials in Koszalin – page 10

Innovative research focusing on bladder cancer and prostate cancer treatments, including combination therapies with immunological agents and targeted treatments.

• Non-muscle invasive bladder cancer therapy
• Metastatic castration-resistant prostate cancer
• Novel immunotherapy combinations

Studies evaluating durvalumab, BCG combinations, and hormone therapy approaches for improved patient outcomes.

Advanced studies in gastric cancer and gastroesophageal junction cancers, focusing on targeted therapies and immunotherapy combinations.

• HER2-positive gastric cancer treatments
• Combination chemotherapy approaches
• Novel antibody therapies

Investigating trastuzumab deruxtecan and other innovative treatment combinations for metastatic disease.

Comprehensive research in non-small cell lung cancer, exploring novel drug combinations and immunotherapy approaches.

• Advanced/metastatic NSCLC treatments
• Immunotherapy combinations
• First-line treatment strategies

Evaluating new therapeutic options including pembrolizumab combinations and investigational agents.

Pioneering research in advanced breast cancer treatment, particularly focusing on hormone receptor-positive, HER2-negative disease.

• HR+/HER2- metastatic breast cancer
• Novel therapeutic combinations
• Targeted therapy approaches

Studies exploring new treatment combinations with CDK4/6 inhibitors and hormone therapy.